Deep Track Capital, LP - Dec 23, 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share
Symbol
RAPT
Shares outstanding
143M shares
Disclosed Ownership
14.1M shares
Ownership
9.87%
Form type
SCHEDULE 13G
Date filed
12/23/2024, 04:42 PM
Date of event
Dec 23, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 9.87% 14.1M 0 14.1M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 9.87% 14.1M 0 14.1M /s/ David Kroin David Kroin, Director
David Kroin 9.87% 14.1M 0 14.1M /s/ David Kroin David Kroin